Adult onset Niemann-Pick type C: 24 month follow-up on miglustat
Objective: To present a rare case of adult onset NPC patient and pointing out varying response of her distinct symptoms on long term follow up…STRONG VOICE: Design of a multisite, open-label, longitudinal registry for patients with neurogenic dysphonia/dysphagia treated with vocal fold augmentation
Objective: To describe the benefits and risks of vocal fold augmentation treatment for patients with neurogenic dysphonia/dysphagia. Background: Neurogenic dysphonia/dysphagia represents laryngeal dysfunction, usually with…Glial cells and iron accumulation in the brain of the Zitter rat
Objective: To investigate relationship between glial cell and iron accumulation in the brain of the Zitter rat, which is one of neurodegenerative disease model. Background:…Improving the experience of diagnosis in Parkinson’s disease
Objective: To identify areas in which patient experience of being diagnosed with Parkinson's can be improved. Background: Receiving a Parkinson's diagnosis can leave patients feeling…Beyond 30 years of Parkinson’s disease: A comprehensive characterization of long-surviving patients
Objective: To analyze the features of very late stage Parkinson's disease (PD) in a selected group of patients treated with bilateral subthalamic nucleus DBS (STN-DBS),…Biochemical features of lipids spectrum in blood in patients with Parkinson’s disease
Objective: To study characteristic of lipid levels in patients with PD. Background: Currently, there is no clear data about the features of lipid metabolism in…How accurate is the prediction of driving ability in a Parkinson’s clinic setting?
Objective: To determine whether routine clinical assessment (motor examination, cognitive assessment and global clinical impression) accurately predicts the ability of People with Parkinson's (PwP) to…Examining the clinical profile of nelotanserin, a novel agent in development for Lewy body dementia
Objective: To examine the clinical profile of nelotanserin, a novel agent in development for the treatment of Lewy body dementia. Background: Although not FDA-approved for…Psychogenic non-epileptic seizures among patients with temporal lobe and other epilepsies: Phenomenology and EEG correlates
Objective: To determine the extent to which cortical epileptic foci of patients with comorbid psychogenic non-epileptic and epileptic seizures (PNES/ES) differ from age- and gender-matched…Combinative therapy of memantine and galantamine hydrobromide as a tool of choice for the treatment of vascular parkinsonism with early appearance of dementia symptoms
Objective: Our primary aim was comparative study of monotherapy with memantine and combinative therapy with memantine and galantamine hydrobromide for treatment of vascular parkinsonism with…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.